Health experts discuss new treatment strategies for lung cancer at AACR-IASLC Joint Conference

What:
Lung cancer kills more people than breast cancer, prostate cancer, kidney cancer, colon cancer, liver cancer and skin cancer combined, and it is the most common cause of cancer death.

In partnership with the International Association for the Study of Lung Cancer, the American Association for Cancer Research will host the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, which will bring together leaders from all over the world who share the goal of eradicating this form of cancer. The conference will open with a keynote lecture from Tyler Jacks, Ph.D., president of the American Association for Cancer Research and director of the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology.

To help you plan your coverage of the conference, the program schedule is available online at www.aacr.org, and an electronic press kit containing the press releases and select highlighted abstracts will be available to subscribing media on Jan. 6, 2010, via Eurekalert, Newswise or by request to the AACR Communications Department.

Findings presented at the meeting will include:
•basic science on the role of microRNAs and cancer stem cells in carcinogenesis development;
•personalized therapies for long cancer—what is ready for prime time;
•new treatment strategies for the hardest to treat subsets of lung cancer; and
•groundbreaking tools for noninvasive diagnosis.

When:
Jan. 11-14, 2010

Where:
Loews Coronado Bay Resort
Coronado, Calif.